Search

Your search keyword '"Ceci G"' showing total 166 results

Search Constraints

Start Over You searched for: Author "Ceci G" Remove constraint Author: "Ceci G"
166 results on '"Ceci G"'

Search Results

56. Drug Prescription and Delirium in Older Inpatients: Results From the Nationwide Multicenter Italian Delirium Day 2015-2016

57. Computational Methods for Protein Fold Prediction: an Ab-initio Topological Approach

58. Postdischarge Clinical Outcomes in Older Medical Patients with an Emergency Department Stay-Associated Delirium Onset

59. 'Delirium Day': a nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool

60. Length of Stay in the Emergency Department and Occurrence of Delirium in Older Medical Patients

61. Lomustine (Chloroethyinitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma

63. Prostaglandin E2 signalling pathway in human T lymphocytes from healthy and conjunctiva basal cell carcinoma-bearing subjects

64. An intermittent recovery test for soccer players: a validation study.

65. Health-related quality of life in outpatients with chronic liver disease: a cross-sectional study.

66. Postdischarge Clinical Outcomes in Older Medical Patients with an Emergency Department Stay-Associated Delirium Onset.

67. Length of Stay in the Emergency Department and Occurrence of Delirium in Older Medical Patients.

68. Use of axillary ultrasonography in breast cancer: a useful tool to reduce sentinel node procedures.

69. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.

70. Campylobacter fetus bacteremia in an immunocompromised patient: case report and review of the literature.

71. Quantitative determination of histamine in tears during conjunctivitis by a novel HPLC method.

72. P-CHOP: cisplatin (P) added to the standard CHOP regimen as first-line treatment for aggressive non-Hodgkin lymphoma: a single-institution phase II study.

73. Compliance and outcomes in locally advanced head and neck cancer patients treated with alternating chemo-radiotherapy in clinical practice.

74. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.

75. Mature results of a prospective randomized trial comparing a three-weekly with an accelerated weekly schedule of cisplatin in advanced ovarian carcinoma.

76. Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial.

77. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.

78. Cisplatin and VP16 in metastatic breast carcinoma as a third-line chemotherapy: a randomized study comparing low versus high doses of cisplatin.

79. Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the Italian Oncology Group for Clinical Research.

80. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen.

81. A phase II study of cisplatin in advanced gastric cancer.

82. Platinum and etoposide in chemotherapy refractory metastatic breast cancer. A phase II trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).

83. Aminoglutethimide in advanced breast cancer.

84. Bone marrow biopsy in the staging of small cell lung cancer.

88. [Gynecologic ureteral lesions].

94. [Physiopathology of the pelvic organs and structures after radical gynecological surgery].

Catalog

Books, media, physical & digital resources